United Therapeutics ROA 2006-2018 | UTHR

Current and historical return on assets (ROA) values for United Therapeutics (UTHR) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. United Therapeutics ROA for the three months ending September 30, 2018 was 19.56%.
United Therapeutics ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $0.54B $3.41B 17.33%
2018-06-30 $0.71B $3.25B 23.61%
2018-03-31 $0.48B $3.02B 16.80%
2017-12-31 $0.42B $2.88B 15.11%
2017-09-30 $0.51B $2.94B 19.36%
2017-06-30 $0.40B $2.69B 16.04%
2017-03-31 $0.66B $2.56B 28.08%
2016-12-31 $0.71B $2.33B 31.77%
2016-09-30 $0.71B $2.27B 32.06%
2016-06-30 $1.01B $2.20B 46.29%
2016-03-31 $0.90B $2.19B 43.71%
2015-12-31 $0.65B $2.18B 32.65%
2015-09-30 $0.66B $2.16B 34.50%
2015-06-30 $0.17B $1.74B 9.12%
2015-03-31 $0.19B $1.90B 9.53%
2014-12-31 $0.34B $1.88B 17.00%
2014-09-30 $0.20B $2.07B 9.48%
2014-06-30 $0.28B $1.95B 14.00%
2014-03-31 $0.25B $2.12B 12.69%
2013-12-31 $0.18B $2.09B 9.34%
2013-09-30 $0.29B $1.93B 16.39%
2013-06-30 $0.30B $1.78B 17.96%
2013-03-31 $0.30B $1.70B 18.08%
2012-12-31 $0.30B $1.63B 19.03%
2012-09-30 $0.26B $1.65B 16.81%
2012-06-30 $0.27B $1.56B 17.14%
2012-03-31 $0.27B $1.56B 17.20%
2011-12-31 $0.22B $1.52B 13.89%
2011-09-30 $0.18B $1.67B 11.94%
2011-06-30 $0.14B $1.58B 9.69%
2011-03-31 $0.10B $1.49B 7.72%
2010-12-31 $0.11B $1.43B 8.51%
2010-09-30 $0.09B $1.28B 8.09%
2010-06-30 $0.07B $1.19B 6.04%
2010-03-31 $0.03B $1.13B 2.51%
2009-12-31 $0.02B $1.05B 2.04%
2009-09-30 $-0.06B $1.01B -6.32%
2009-06-30 $-0.06B $0.95B -6.86%
2009-03-31 $-0.05B $0.90B -5.71%
2008-12-31 $-0.05B $0.88B -6.62%
2008-09-30 $0.03B $0.77B 4.04%
2008-06-30 $0.03B $0.68B 5.13%
2008-03-31 $0.03B $0.64B 4.52%
2007-12-31 $0.01B $0.59B 2.39%
2007-09-30 $0.07B $0.51B 15.60%
2007-06-30 $0.07B $0.47B 15.92%
2007-03-31 $0.07B $0.44B 17.97%
2006-12-31 $0.07B $0.48B 21.07%
2006-09-30 $0.05B $0.30B 15.42%
2006-06-30 $0.06B $0.33B 18.68%
2006-03-31 $0.06B $0.31B 21.71%
2005-12-31 $0.07B $0.29B 26.03%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $4.913B $1.725B
United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions. United Therapeutics (UT) has an overarching commitment to environmental sustainability. The company's product candidates include Adcirca is a phosphodiesterase 5 (PDE-5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH)(WHO Group 1) to improve exercise ability in PAH patients. Orenitram is a prostacyclin vasodilator indicated for treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise capacity. Remodulin is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) to diminish symptoms associated with exercise. Tyvaso is a prostacyclin vasodilator indicated for the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $54.973B 11.77
Zoetis (ZTS) United States $45.244B 30.98
Grifols (GRFS) Spain $14.428B 17.61
Tilray (TLRY) United States $10.390B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $9.090B 13.05
Neurocrine Biosciences (NBIX) United States $9.023B 1990.00
Ionis Pharmaceuticals (IONS) United States $7.117B 0.00
Nektar Therapeutics (NKTR) United States $6.465B 9.27
Impax Laboratories (AMRX) United States $5.751B 30.59
Catalent (CTLT) United States $5.556B 23.31
Sage Therapeutics (SAGE) United States $5.112B 0.00
Loxo Oncology (LOXO) United States $4.870B 0.00
Taro Pharmaceutical Industries (TARO) Israel $4.002B 14.82
FibroGen (FGEN) United States $3.456B 0.00
Endo (ENDP) Ireland $3.033B 4.65
USANA Health Sciences (USNA) United States $2.883B 24.54
Madrigal Pharmaceuticals (MDGL) United States $2.251B 0.00
Xencor (XNCR) United States $2.152B 0.00
Heron Therapeutics (HRTX) United States $2.119B 0.00
Aerie Pharmaceuticals (AERI) United States $1.969B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.968B 265.94
Endocyte (ECYT) United States $1.936B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.752B 0.00
Zogenix (ZGNX) United States $1.677B 0.00
PTC Therapeutics (PTCT) United States $1.613B 0.00
TESARO (TSRO) United States $1.612B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.491B 18.24
Corcept Therapeutics (CORT) United States $1.446B 21.22
Spectrum Pharmaceuticals (SPPI) United States $1.367B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.364B 0.00
Esperion Therapeutics (ESPR) United States $1.341B 0.00
Portola Pharmaceuticals (PTLA) United States $1.334B 0.00
Tricida (TCDA) United States $1.233B 0.00
TherapeuticsMD (TXMD) United States $1.132B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.098B 0.00
ImmunoGen (IMGN) United States $0.832B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.783B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.704B 0.00
Radius Health (RDUS) United States $0.693B 0.00
Karyopharm Therapeutics (KPTI) United States $0.667B 0.00
Flexion Therapeutics (FLXN) United States $0.621B 0.00
Collegium Pharmaceutical (COLL) United States $0.570B 0.00
GlycoMimetics (GLYC) United States $0.514B 0.00
ChemoCentryx (CCXI) United States $0.471B 37.28
Dova Pharmaceuticals (DOVA) United States $0.467B 0.00
OptiNose (OPTN) United States $0.465B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.448B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.445B 0.00
Akebia Therapeutics (AKBA) United States $0.444B 0.00
Odonate Therapeutics (ODT) United States $0.442B 0.00
Siga Technologies (SIGA) United States $0.431B 0.00
Aquestive Therapeutics (AQST) United States $0.430B 0.00
Xeris Pharmaceuticals (XERS) United States $0.428B 0.00
Dermira (DERM) United States $0.427B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.419B 24.70
Forty Seven (FTSV) United States $0.407B 0.00
Zafgen (ZFGN) United States $0.402B 0.00
ArQule (ARQL) United States $0.400B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.394B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.391B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.364B 0.00
Depomed (ASRT) United States $0.344B 12.81
Mast Therapeutics (SVRA) United States $0.331B 0.00
Minerva Neurosciences (NERV) United States $0.317B 0.00
Aratana Therapeutics (PETX) United States $0.313B 0.00
Tapimmune (MRKR) United States $0.309B 0.00
Aclaris Therapeutics (ACRS) United States $0.299B 0.00
Majesco Entertainment (PTE) United States $0.298B 0.00
KalVista Pharmaceuticals (KALV) United States $0.296B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.295B 0.00
CASI Pharmaceuticals (CASI) United States $0.286B 0.00
Translate Bio (TBIO) United States $0.284B 0.00
Concert Pharmaceuticals (CNCE) United States $0.277B 0.00
IMV INC (IMV) Canada $0.245B 0.00
Opexa Therapeutics (ACER) United States $0.237B 0.00
Affimed (AFMD) Germany $0.235B 0.00
Ocular Therapeutix (OCUL) United States $0.217B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.216B 0.00
Tyme Technologies (TYME) United States $0.214B 0.00
MEI Pharma (MEIP) United States $0.213B 0.00
Lannett Co Inc (LCI) United States $0.212B 1.85
Aldeyra Therapeutics (ALDX) United States $0.212B 0.00
ElectroCore (ECOR) United States $0.201B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.201B 0.00
Redhill Biopharma (RDHL) Israel $0.199B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.196B 0.00
Galectin Therapeutics (GALT) United States $0.194B 0.00
Neon Therapeutics (NTGN) United States $0.193B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.188B 0.00
Calithera Biosciences (CALA) United States $0.187B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.183B 0.00
Ardelyx (ARDX) United States $0.173B 0.00
Nature's Sunshine Products (NATR) United States $0.172B 0.00
ContraFect (CFRX) United States $0.166B 0.00
Molecular Templates (MTEM) United States $0.161B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.156B 0.00
MediWound (MDWD) Israel $0.154B 0.00
Melinta Therapeutics (MLNT) United States $0.150B 0.00
Recro Pharma (REPH) United States $0.147B 0.00
Jounce Therapeutics (JNCE) United States $0.144B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.141B 0.00
Champions Oncology (CSBR) United States $0.140B 0.00
DURECT (DRRX) United States $0.139B 0.00
Adherex Technologies (FENC) United States $0.129B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.129B 0.00
ProNAi Therapeutics (SRRA) Canada $0.123B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.122B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.110B 0.00
Cardiome Pharma (CORV) Canada $0.109B 0.00
Rafael Holdings (RFL) United States $0.107B 0.00
CTI BioPharma (CTIC) United States $0.097B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.097B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.093B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.093B 0.00
Achaogen (AKAO) United States $0.089B 0.00
Iterum Therapeutics (ITRM) Ireland $0.083B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.081B 0.00
Infinity Pharmaceuticals (INFI) United States $0.077B 0.00
Otonomy (OTIC) United States $0.074B 0.00
Nivalis Therapeutics (ALPN) United States $0.071B 0.00
BioLineRx (BLRX) Israel $0.071B 0.00
Natural Alternatives (NAII) United States $0.070B 6.94
Neos Therapeutics (NEOS) United States $0.066B 0.00
Immune Design (IMDZ) United States $0.066B 0.00
Novan (NOVN) United States $0.065B 0.00
Forward Pharma (FWP) Denmark $0.064B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.063B 39.31
Ampio Pharmaceuticals (AMPE) United States $0.062B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.059B 0.00
Genocea Biosciences (GNCA) United States $0.053B 0.00
Avenue Therapeutics (ATXI) United States $0.049B 0.00
Capnia (SLNO) United States $0.044B 0.00
Mannatechorporated (MTEX) United States $0.041B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.040B 0.00
SCYNEXIS (SCYX) United States $0.039B 0.00
KemPharm (KMPH) United States $0.039B 0.00
Trillium Therapeutics (TRIL) Canada $0.039B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.039B 0.00
Heat Biologics (HTBX) United States $0.037B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.036B 0.00
ProPhase Labs (PRPH) United States $0.035B 3.94
Lipocine (LPCN) United States $0.034B 0.00
IsoRay (ISR) United States $0.028B 0.00
Can-Fite Biopharma (CANF) Israel $0.028B 0.00
Biomerica (BMRA) United States $0.026B 0.00
Onconova Therapeutics (ONTX) United States $0.024B 0.00
Jaguar Animal Health (JAGX) United States $0.023B 0.00
Xenetic Biosciences (XBIO) United States $0.023B 0.00
HANCOCK JAFFE (HJLI) United States $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.022B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.021B 0.00
NanoViricides (NNVC) United States $0.021B 0.00
Cyanotech (CYAN) United States $0.021B 0.00
ESSA Pharma (EPIX) Canada $0.020B 0.00
Pain Therapeutics (PTIE) United States $0.020B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.020B 7.15
NovaBay Pharmaceuticals (NBY) United States $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.018B 0.00
Aviragen Therapeutics (VXRT) United States $0.018B 0.00
Aradigm (ARDM) United States $0.017B 0.00
Shineco (TYHT) China $0.016B 1.58
DelMar Pharmaceuticals (DMPI) Canada $0.014B 0.00
Regulus Therapeutics (RGLS) United States $0.013B 0.00
Skyline Medical (AIPT) United States $0.012B 0.00
Midatech Pharma (MTP) United Kingdom $0.011B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.011B 0.00
Apricus Biosciences (APRI) United States $0.009B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
PharmAthene (ALT) United States $0.006B 0.00
Bio-Path Holdings (BPTH) United States $0.006B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.005B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.004B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.004B 0.00
Intellipharmaceutics (IPCI) Canada $0.002B 0.00
RXi Pharmaceuticals (RXII) United States $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00